• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
98% Bifida Ferment Lysate
rhSOD (cosmetic grade)
Recombinant humanized collagen
Recombinant Humanized Small-molecule Collagen
Recombinant Humanized Small-molecule Collagen Solution
rhSOD

Dr Reddy’s announces launch of Colchicine Tablets USP in the US

expresspharmaJune 16, 2020

Tag: Dr Reddy , Colchicine Tablets , FDA

Dr Reddy’s Laboratories announced the launch of Colchicine Tablets USP, a therapeutic equivalent generic version of Colcrys (colchicine) Tablets, 0.6 mg, approved by the US Food and Drug Administration (USFDA).

The Colcrys brand and generic market had US sales of approximately $491 million MAT for the most recent twelve months ending in March 2020 according to IQVIA Health*.

Dr Reddy’s Colchicine is available in 0.6 mg tablets in bottle count sizes of 30s and 100s.


Previous:Caplin Steriles gets USFDA approval for Phenylephrine Hydrochloride Injection USP

Next:Pricing problems: Aurobindo Pharma, Sun Pharma, Lupin named in lawsuit in US

Related News

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

A New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

Dr Reddy’s announces launch of Colchicine Tablets USP in the US | Pharmasources.com

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

PRNewswireDecember 21, 2024

Corvia Medical, Inc.announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745).

You may like
More>>

Ribavirin (FDA)

Ribavirin (FDA)
Adriacin HCL (FDA)

Adriacin HCL (FDA)
Mitomycin ( FDA)

Mitomycin ( FDA)
Ramantadine( FDA)

Ramantadine( FDA)
Mesnaum (FDA)

Mesnaum (FDA)
Vecuronium Bromide(FDA)

Vecuronium Bromide(FDA)
Nabumetone (FDA)

Nabumetone (FDA)
9,9-Bis(4-aminophenyl) Fluorene (FDA)

9,9-Bis(4-aminophenyl) Fluorene (FDA)
Vitamine B12 (FDA)

Vitamine B12 (FDA)
filter integrity testing fda guidelines

filter integrity testing fda guidelines

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service